Lungpacer Announces Health Economic Analysis Demonstrating Clinical and Cost Benefits of AeroPace in Mechanically Ventilated Patients

Analysis projects national average cost savings of ~$24,000 per episode alongside improved ventilator weaning outcomes EXTON, Pa., July 28, 2026 (GLOBE NEWSWIRE) — Lungpacer Medical today announced results from a new health economic analysis demonstrating that the AeroPace® System, a temporary transvenous diaphragm neurostimulation therapy, is projected to deliver meaningful cost savings for hospitals and […]